BioWorld - Wednesday, June 3, 2026

BioWorld Science

July 19, 2021

View Archived Issues

HER2 CAR-NK cells show preclinical antitumor activity without off-target cytotoxicity

Read More

TGF-beta-mediated mTOR inhibition preserves cellular metabolism of precursors of exhausted T cells

Read More

New prosthetic valvular graft infection model shows benefit of adjunctive fibrinolytic treatment

Read More

Model of steroid-resistant neutrophilic asthma developed to test treatments

Read More

GFAP a biomarker in frontotemporal lobar degeneration and primary psychiatric disorders

Read More

TYK Medicines divulges new Ret inhibitors

Read More

Wigen Biomedicine Technology presents KRAS mutant inhibitors

Read More

FDA accepts IND application for phase IIa study of Quilience as treatment of narcolepsy

Read More

UCB discloses new FCER1A mutant inhibitors

Read More

FDA clears IND for phase I trial of SYSA-1801 in advanced pancreatic cancer

Read More

Phase I trial investigates SHJ-002 for myopia in pediatric subjects

Read More

ABBV-CLS-7262 studied in phase I for ALS

Read More

BIX-119 leads to improved clinical benefit through blocking both IL-17 and IL-22

Read More

Scioto opens phase I study of SB-121 in participants with autistic disorder

Read More

New neonatal murine model of Listeria monocytogenes meningitis developed

Read More

Clarity recruits patients with prostate cancer to evaluate PET imaging with [64Cu]SAR-bisPSMA

Read More

Discovery of novel selective Axl inhibitor with antitumor activity in vivo

Read More

Phase II/III trial studies SHR-1701 with BP-102 and XELOX in first-line metastatic colorectal cancer

Read More

U.S. phase II trial explores use of Velexbru in primary central nervous system lymphoma

Read More

CytoDyn reports preliminary data on leronlimab in metastatic TNBC

Read More